Phosphatidylcholine (LT-02) for Induction of Remission in Ulcerative Colitis

NCT02142725 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

468

Enrollment

INDUSTRY

Sponsor class

Stopped IDMC recommendation

Conditions

Ulcerative Colitis

Interventions

DRUG: LT-02
DRUG: LT-02
DRUG: Placebo

Sponsor

Dr. Falk Pharma GmbH